Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 6178 [2018-02827]
Download as PDF
<![CDATA[
6178
Federal Register / Vol. 83, No. 30 / Tuesday, February 13, 2018 / Notices
Date: April 18, 2018.
Time: 10:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop F80,
Atlanta, Georgia 30341, Telephone: (770)
488–6511, kva5@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–02825 Filed 2–12–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ACBCYW. The ACBCYW consists of 15
experts in fields associated with breast
cancer, disease prevention, early
detection, diagnosis, public health,
social marketing, genetic screening and
counseling, treatment, rehabilitation,
palliative care, and survivorship in
young women, or in related disciplines
with a specific focus on young women.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of breast
health, breast cancer, disease prevention
and risk reduction, survivorship
(including metastatic breast cancer),
hereditary breast and ovarian cancer
(HBOC), or in related disciplines with a
specific focus on young women. Persons
with personal experience with early
onset breast cancer are also eligible to
apply. This includes, but may not be
limited to breast cancer survivors <45
years of age and caregivers of said
persons. Federal employees will not be
considered for membership. Members
may be invited to serve up to four-year
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
23:12 Feb 12, 2018
Jkt 244001
terms. Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACBCYW
objectives (https://www.cdc.gov/maso/
facm/facmacbcyw.html).
DATES: Nominations for membership on
the ACBCYW must be received no later
than March 26, 2018. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Temeika L. Fairley, Ph.D.
c/o ACBCYW Secretariat, Centers for
Disease Control and Prevention, 3719
North Peachtree Road, Building 100
Chamblee, Georgia 30341, or emailed
(recommended) to acbcyw@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE, Mailstop F–76, Atlanta, Georgia
30341; 770–488–4518; acbcyw@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACBCYW membership each year,
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in December 2018,
or as soon as the HHS selection process
is completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. Government. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
(telephone numbers, mailing address,
email address);
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–02827 Filed 2–12–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of closed meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP) Funding Opportunity
Announcement (FOA), PAR 16–098,
Cooperative Research Agreements to the
World Trade Center Health Program (U01).
Dates: April 11, 2018 and April 12, 2018.
Times: 8:00 a.m.–5:00 p.m., EDT, April 11,
2018 and 8:00 a.m.–2:00 p.m. EDT, April 12,
2017.
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Notices]
[Page 6178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02827]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Breast Cancer in Young Women (ACBCYW)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the ACBCYW. The ACBCYW consists
of 15 experts in fields associated with breast cancer, disease
prevention, early detection, diagnosis, public health, social
marketing, genetic screening and counseling, treatment, rehabilitation,
palliative care, and survivorship in young women, or in related
disciplines with a specific focus on young women. Nominations are being
sought for individuals who have expertise and qualifications necessary
to contribute to the accomplishments of the committee's objectives.
Nominees will be selected based on expertise in the fields of breast
health, breast cancer, disease prevention and risk reduction,
survivorship (including metastatic breast cancer), hereditary breast
and ovarian cancer (HBOC), or in related disciplines with a specific
focus on young women. Persons with personal experience with early onset
breast cancer are also eligible to apply. This includes, but may not be
limited to breast cancer survivors <45 years of age and caregivers of
said persons. Federal employees will not be considered for membership.
Members may be invited to serve up to four-year terms. Selection of
members is based on candidates' qualifications to contribute to the
accomplishment of ACBCYW objectives (https://www.cdc.gov/maso/facm/facmacbcyw.html).
DATES: Nominations for membership on the ACBCYW must be received no
later than March 26, 2018. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Temeika L. Fairley,
Ph.D. c/o ACBCYW Secretariat, Centers for Disease Control and
Prevention, 3719 North Peachtree Road, Building 100 Chamblee, Georgia
30341, or emailed (recommended) to [email protected].
FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for Chronic Disease Prevention and
Health Promotion, CDC, 4770 Buford Highway NE, Mailstop F-76, Atlanta,
Georgia 30341; 770-488-4518; [email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens, and cannot be full-time employees of
the U.S. Government. Current participation on federal workgroups or
prior experience serving on a federal advisory committee does not
disqualify a candidate; however, HHS policy is to avoid excessive
individual service on advisory committees and multiple committee
memberships. Committee members are Special Government Employees,
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
ACBCYW membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
December 2018, or as soon as the HHS selection process is completed.
Note that the need for different expertise varies from year to year and
a candidate who is not selected in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and cannot be full-time employees
of the U.S. Government. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address);
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-02827 Filed 2-12-18; 8:45 am]
BILLING CODE 4163-18-P
